Terms: = Thyroid cancer AND Ki-67 AND Treatment
87 results:
1. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
3. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in thyroid cancer Cells.
Zhang Y; Han Y; Dong J; Li F; Sun Y
Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
5. LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical cancer.
Liang M; Li Y; Chen C
Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
[TBL] [Abstract] [Full Text] [Related]
6. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
7. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma.
Yue W; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1025629. PubMed ID: 36506082
[TBL] [Abstract] [Full Text] [Related]
8. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
9. Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer.
Wu K; Zhang H; Zhou L; Chen L; Mo C; Xu S; Lin J; Kong L; Chen X
Exp Cell Res; 2022 Dec; 421(1):113362. PubMed ID: 36152730
[TBL] [Abstract] [Full Text] [Related]
10. The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score.
Yang ZJ; Liu YX; Huang Y; Chen ZJ; Zhang HZ; Yu Y; Wang X; Cao XC
Cancer Med; 2023 Feb; 12(3):2493-2504. PubMed ID: 35909232
[TBL] [Abstract] [Full Text] [Related]
11. CircRTN1 acts as a miR-431-5p sponge to promote thyroid cancer progression by upregulating TGFA.
Gao Y; Wang Y; Xu L; Xie X; Zhu L; Wang F
Hormones (Athens); 2022 Dec; 21(4):611-623. PubMed ID: 35804263
[TBL] [Abstract] [Full Text] [Related]
12. Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
Czajkowski M; Kaemmerer D; Sänger J; Sauter G; Wirtz RM; Schulz S; Lupp A
BMC Cancer; 2022 Jul; 22(1):740. PubMed ID: 35799158
[TBL] [Abstract] [Full Text] [Related]
13. Sintilimab in Patients with Previously Treated Metastatic Neuroendocrine Neoplasms.
Jia R; Li Y; Xu N; Jiang HP; Zhao CH; Liu RR; Shi Y; Zhang YY; Wang SY; Zhou H; Xu JM
Oncologist; 2022 Aug; 27(8):e625-e632. PubMed ID: 35647908
[TBL] [Abstract] [Full Text] [Related]
14. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
Ding C; Shi T; Wu G; Man J; Han H; Cui Y
Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
[TBL] [Abstract] [Full Text] [Related]
15. miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1.
Zhao W; Zhao Y; Chen L; Sun Y; Fan S
Comput Math Methods Med; 2022; 2022():2329576. PubMed ID: 35082911
[TBL] [Abstract] [Full Text] [Related]
16. [Endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
17. Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy.
Hou N; Wu J; Xiao J; Wang Z; Song Z; Ke Z; Wang R; Wei M; Xu M; Wei J; Qian X; Xu X; Yi J; Wang T; Zhang J; Li N; Fan J; Hou G; Wang Y; Wang Z; Ling R
ESMO Open; 2021 Oct; 6(5):100269. PubMed ID: 34537675
[TBL] [Abstract] [Full Text] [Related]
18. [Merkel cell carcinoma: a clinicopathological study of 10 cases].
Luo YY; Su QJ; Zhu YJ; Ji PZ; Ma JW; Liu B; Yang YL
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):915-918. PubMed ID: 34344076
[No Abstract] [Full Text] [Related]
19. [Application of BRAF in the diagnosis and treatment of thyroid papillary carcinoma].
Zou T; Pan Y; Wang LX
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):629-634. PubMed ID: 34289553
[TBL] [Abstract] [Full Text] [Related]
20. Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study.
Wang Y; Zhou R; Zhang X; Liu H; Shen D; Wang J
BMC Womens Health; 2021 Jun; 21(1):252. PubMed ID: 34162378
[TBL] [Abstract] [Full Text] [Related]
[Next]
